What Is a Transudative Effusion and What Causes It?

A transudative effusion is a buildup of fluid in a body cavity, most commonly around the lungs, caused not by infection or inflammation but by an imbalance in the pressures that normally keep fluid where it belongs. The fluid itself is thin and low in protein because it leaks through intact membranes rather than being pushed out by damaged or inflamed tissue. Heart failure is the single most common cause, but liver disease, kidney problems, and a handful of rarer conditions can produce the same result. Understanding how transudative effusions form, what causes them, and how they are distinguished from the other major category of effusion matters because the treatment strategy is fundamentally different: you treat the underlying condition, not the fluid itself.

How Fluid Ends Up Where It Should Not Be

The space between your lungs and the chest wall, called the pleural space, normally contains only a thin film of fluid that lets the lung surfaces glide smoothly during breathing. That small amount of fluid is constantly being produced and reabsorbed in a tightly regulated cycle. The balance depends on what are known as Starling forces: the push of blood pressure inside tiny capillaries versus the pull of proteins in the blood that draw fluid back in. When those pressures shift, fluid filters out of capillaries faster than it can be reabsorbed, and it pools in the pleural space.

In a transudative effusion, the membranes lining the pleural space remain structurally intact. Nothing is inflamed, torn, or invaded by infection. The fluid accumulates simply because the physics of pressure and protein concentration have tipped out of balance.

¹ This is the key distinction from an exudative effusion, where the pleural lining is damaged by disease processes like infection, cancer, or autoimmune conditions, allowing protein-rich, inflammatory fluid to leak through.

Heart Failure as the Leading Cause

Congestive heart failure accounts for the largest share of transudative pleural effusions. When the left side of the heart cannot pump blood forward efficiently, pressure backs up into the pulmonary veins and capillaries. That elevated pressure forces more fluid out of the capillary walls and into the lung tissue. Some of that excess interstitial fluid then crosses into the pleural space.

Research comparing heart failure patients with and without pleural effusions found that left-sided heart pressures were the critical factor. Patients who developed effusions had significantly higher pulmonary artery wedge pressures, averaging about 24 mmHg versus roughly 17 mmHg in those without effusions. Right-sided heart pressures, by contrast, did not differ meaningfully between the two groups.

³ The mechanism also involves reduced lymphatic drainage: when central venous pressures are high, the lymphatic vessels that normally vacuum fluid out of the pleural space have a harder time emptying into the great veins.

⁴

Liver Cirrhosis and Hepatic Hydrothorax

Severe liver disease, particularly cirrhosis with portal hypertension, can produce a transudative pleural effusion through a surprisingly direct route. In these patients, fluid first accumulates in the abdomen as ascites. Tiny defects in the diaphragm, sometimes microscopic, allow that ascitic fluid to pass directly from the abdominal cavity into the chest. The negative pressure generated by each breath acts like a vacuum, pulling fluid upward through those defects. This condition, called hepatic hydrothorax, typically produces effusions larger than 500 mL and occurs even in patients with no primary heart or lung disease.

⁵

Hepatic hydrothorax overwhelmingly favors the right side of the chest, which is thought to relate to both the anatomy of diaphragmatic defects and the distribution of pressure from ascites. It can develop even when visible ascites is minimal, which sometimes delays diagnosis because clinicians may not immediately suspect the liver as the source of a chest problem.

Does Low Albumin Alone Cause Effusions?

You might expect that conditions causing very low blood protein levels, like nephrotic syndrome or severe malnutrition, would be a straightforward cause of transudative effusions. The logic seems simple: less protein in the blood means less osmotic pull to keep fluid inside the capillaries, so fluid leaks out. And while low albumin does appear in textbook lists of transudative effusion causes, the evidence that it works as a standalone cause is surprisingly weak.

A study specifically investigating this question found that among patients with low serum albumin levels, almost all of the pleural effusions that developed could be explained by other conditions when records were carefully reviewed. None of the patients whose albumin dropped to 3.5 g/dL or below had an effusion that could not be attributed to some other cause.

⁶ This does not mean low albumin plays no role. It likely acts as a contributing factor that worsens effusions triggered by other conditions, rather than causing them on its own. For patients with nephrotic syndrome who develop effusions, the combination of low albumin and fluid overload is usually at work, not albumin depletion in isolation.

How Doctors Tell a Transudate From an Exudate

Distinguishing transudative from exudative effusions matters because it changes the entire diagnostic and treatment approach. A transudative effusion points toward a systemic problem like heart failure or liver disease, while an exudative effusion suggests a local process such as pneumonia, cancer, or tuberculosis. The primary tool for making this distinction has been the same since the early 1970s: a set of laboratory cutoffs applied to fluid removed during a procedure called thoracentesis.

These cutoffs, known as Light’s criteria, classify an effusion as exudative if any one of three thresholds is met: a pleural fluid protein ratio above a certain level compared to blood, a pleural fluid LDH above a certain level, or a pleural fluid to serum LDH ratio above a defined threshold. If none of the three is met, the effusion is classified as a transudate. The criteria are remarkably sensitive for catching exudates, correctly identifying them about 98% of the time.

⁷ But that high sensitivity comes at a cost: the specificity for ruling out transudates is only moderate, landing around 77% in some analyses.

⁸

In practical terms, the system is designed to avoid missing a serious exudative cause. The tradeoff is that it sometimes mislabels a true transudate as an exudate, which can trigger unnecessary further testing.

The Pseudoexudate Problem

One of the most common clinical headaches with transudative effusions involves patients whose fluid gets wrongly classified as exudative. This happens frequently in heart failure patients receiving diuretic therapy. Diuretics concentrate the pleural fluid by pulling water out of the body, which raises the protein and LDH levels in the remaining fluid above the exudative cutoffs. Roughly one in five heart failure patients on diuretics may have their transudative effusion mislabeled this way.

⁹

These misclassified effusions are called pseudoexudates. In one study, more than a third of heart failure patients with pleural effusions were falsely labeled as having exudative fluid by Light’s criteria.

¹⁰ The consequence is not trivial: an exudative classification can prompt invasive procedures, biopsies, and imaging workups that the patient does not actually need.

Several workarounds exist. The serum-to-pleural-fluid albumin gradient compares albumin levels in the blood and the effusion. If the difference is greater than 1.2 g/dL, the effusion is more likely a transudate regardless of what Light’s criteria say. In one analysis, combining the albumin gradient with the protein gradient yielded perfect sensitivity for identifying pseudoexudates in heart failure patients and near-perfect sensitivity for hepatic hydrothorax.

¹¹

Another approach uses a blood marker called NT-proBNP, a protein released by the heart when it is under strain. When pleural fluid NT-proBNP is elevated, it strongly suggests a cardiac origin even if Light’s criteria point toward an exudate. In the study mentioned above where a third of heart failure effusions were mislabeled, every one of those misclassified patients had NT-proBNP levels above 4,000 ng/L.

¹² Comparing approaches head-to-head, NT-proBNP and the albumin gradient each correctly reclassified about three-quarters of misclassified cardiac effusions, outperforming the protein gradient alone.

¹³

More recent research has explored whether Light’s criteria could be replaced entirely with tests that do not require a simultaneous blood draw. A validated combination of pleural fluid tests alone matched the diagnostic accuracy of Light’s criteria across a dataset of over 7,000 patients, which could simplify the process and reduce errors in settings where blood sampling is delayed or impractical.

¹⁴

Less Common and Rare Causes

Beyond heart failure and liver disease, transudative effusions occasionally show up in less expected contexts. Hypothyroidism can produce pleural effusions, though the mechanism is not fully understood. It may involve a combination of reduced albumin production by the liver and increased leakiness of blood vessels, possibly driven by hormonal signaling that stimulates the production of vascular growth factors.

¹⁵

Urinothorax is another rare but fascinating cause. When urine leaks from an obstructed or injured urinary tract, it can track through tissues and enter the pleural space, either through lymphatic channels in the diaphragm or through small defects. The resulting fluid is transudative, has a pH below 7.30, and literally smells like urine.

¹⁶ Interestingly, the effusion does not always appear on the same side as the kidney problem. Urine can cross over via peritoneal or lymphatic routes, so a left-sided effusion can result from a right-sided urinary obstruction.

¹⁷

Superior vena cava obstruction represents another path to transudative effusions. When the large vein draining blood from the upper body becomes blocked, usually by a tumor or a blood clot, the backed-up pressure in local venous networks can push fluid into the pleural space.

¹⁸

One diagnostic pitfall worth flagging: pulmonary embolism, or a blood clot in the lung, can cause pleural effusions, and clinicians sometimes wonder if those effusions could be transudative. They are not. A study of 60 patients with pulmonary embolism found that every single effusion was exudative, and about two-thirds contained significant amounts of red blood cells. If someone with a pleural effusion has transudative fluid, that fluid should not be blamed on a pulmonary embolism before other causes have been investigated.

¹⁹

Peritoneal Dialysis and Pleuroperitoneal Leaks

Patients on peritoneal dialysis, where a sugar-rich solution is infused into the abdomen to filter waste products, occasionally develop transudative pleural effusions through a mechanism similar to hepatic hydrothorax. If a communication exists between the abdominal and pleural cavities, the dialysis fluid migrates into the chest. This complication affects roughly 2% of patients on continuous ambulatory peritoneal dialysis.

²⁰

These cases have a distinctive diagnostic clue. Because the dialysis fluid is loaded with dextrose, the pleural fluid glucose level is markedly higher than the blood glucose level, which is the reverse of what happens in nearly every other type of effusion.

²¹ Once suspected, the communication can be confirmed with imaging studies that track tagged fluid or contrast from the abdomen into the chest. When the leak is confirmed and does not seal on its own, surgical repair of the diaphragmatic defect, sometimes combined with pleurodesis to glue the lung surface to the chest wall, is an option.

²²

Treatment Focuses on the Cause, Not the Fluid

The central principle with transudative effusions is that draining the fluid treats the symptom, not the disease. For heart failure, optimizing medications (diuretics, blood pressure drugs, and agents that reduce the heart’s workload) shrinks the effusion by addressing the pressure imbalance driving it. For liver cirrhosis, managing sodium intake, using diuretics carefully, and in some cases pursuing liver transplantation are the primary strategies. Thyroid replacement resolves hypothyroid effusions. Relieving urinary obstruction clears urinothorax.

Thoracentesis, the procedure where a needle drains fluid from the pleural space, is used when the effusion is large enough to cause breathing difficulty or when a fluid sample is needed for diagnosis. Ultrasound guidance has substantially improved the safety of this procedure. In one large series using real-time ultrasound, the rate of complications was under 1%, with only a handful of patients developing a small, self-resolving pneumothorax.

²³ A meta-analysis comparing ultrasound-guided thoracentesis to the older landmark-based approach found far fewer pneumothorax events with ultrasound: roughly 1 in 99 patients versus 20 in 113.

²⁴

One risk that applies regardless of technique is re-expansion pulmonary edema, a rare complication where the lung tissue, after being compressed by fluid for a prolonged period, develops swelling when it re-inflates. Both the volume drained and the duration of lung collapse influence the risk. Case reports have documented this complication even after draining relatively modest volumes like 800 mL, particularly in patients with underlying heart disease.

²⁵ The causes are likely multiple, including changes in surfactant, capillary permeability, and pulmonary artery pressures.

²⁶

What Happens When the Effusion Keeps Coming Back

Some patients, particularly those with advanced heart failure or end-stage liver disease, develop effusions that return despite maximal medical treatment. These refractory transudative effusions present a genuine management challenge. Repeated thoracentesis works but means repeated procedures, each carrying a small risk and requiring a hospital or clinic visit.

An alternative is an indwelling pleural catheter, a small tube tunneled under the skin that allows the patient or a caregiver to drain fluid at home as needed. A randomized trial comparing these catheters to repeated thoracentesis in patients with refractory transudative effusions found no significant difference in breathlessness relief over 12 weeks. However, the indwelling catheter group needed far fewer trips back for invasive pleural procedures. The tradeoff was a higher rate of adverse events in the catheter group, including infection and catheter-related problems.

²⁷ Given that these patients tend to have poor overall prognoses and are often on blood thinners, the choice between repeated taps and a permanent catheter comes down to individual circumstances and preferences rather than a clear winner.

²⁸

The Phantom Tumor on a Chest X-Ray

One of the more curious radiological findings associated with transudative effusions is the so-called phantom tumor, also known as a vanishing tumor. In patients with heart failure, fluid occasionally becomes trapped within a lung fissure, the natural dividing line between lung lobes, rather than pooling freely in the pleural space. On a chest X-ray, this loculated fluid looks exactly like a solid mass, sometimes impressively large, mimicking a lung tumor.

²⁹

The giveaway is what happens when the heart failure is treated. Diuretics and fluid restriction cause the “tumor” to vanish within days, sometimes even hours, which is not something any real tumor does. One reported case documented a dense, sharply outlined shadow measuring roughly 10 by 7 centimeters that resolved completely within three days of diuretic therapy.

³⁰ Recognizing this possibility in heart failure patients can spare them from unnecessary biopsies and CT-guided procedures. Whenever a new lung mass appears in someone with known heart failure, treating the heart failure first and repeating the imaging is the recommended approach before pursuing invasive workups.

³¹

1
PubMed Central. Clinical overview of the physiology and pathophysiology of pleural fluid movement: a narrative review ↩︎
2
PubMed. Pleural effusions from congestive heart failure ↩︎
3
American Review of Respiratory Disease. Relationship of Pleural Effusions to Pulmonary Hemodynamics in Patients with Congestive Heart Failure ↩︎
4
PubMed. Pleural Effusions in Patients With Congestive Heart Failure: Frequency, Pathogenesis, Diagnosis, and Implications ↩︎
5
PubMed Central. Hepatic hydrothorax: Current concepts ↩︎
6
Chest. Hypoalbuminemia as a Cause of Pleural Effusions ↩︎
7
Chest. Evaluation of Different Criteria for the Separation of Pleural Transudates From Exudates ↩︎
8
PubMed. A study of Light’s criteria and possible modifications for distinguishing exudative from transudative pleural effusions ↩︎
9
PubMed Central. Comparison of the Efficacy of Light’s Criteria With Serum-Effusion Albumin Gradient and Pleural Effusion Glucose ↩︎
10
European Respiratory Journal. High diagnostic accuracy of NT-proBNP for cardiac origin of pleural effusions ↩︎
11
PubMed. A practical approach to pseudoexudative pleural effusions ↩︎
12
European Respiratory Journal. High diagnostic accuracy of NT-proBNP for cardiac origin of pleural effusions ↩︎
13
PubMed. Comparing serum and pleural fluid pro-brain natriuretic peptide (NT-proBNP) levels with pleural-to-serum albumin gradient for the identification of cardiac effusions misclassified by Light’s criteria ↩︎
14
ERJ Open Research. Revisiting Light’s criteria: a validated blood-free triple combination matches diagnostic accuracy in over 7000 patients ↩︎
15
PubMed Central. Isolated Unilateral Pleural Effusion Associated With Hypothyroidism: A Case Report and Review of the Literature ↩︎
16
PubMed Central. Urinothorax: A Rare Cause of Pleural Effusion ↩︎
17
PubMed. Unilateral urinothorax can occur contralateral to the affected kidney ↩︎
18
European Respiratory Journal Open Research. Pleural transudate: pathophysiology during superior vena cava syndrome ↩︎
19
PubMed. Biochemical and cytologic characteristics of pleural effusions secondary to pulmonary embolism ↩︎
20
PubMed Central. The Use of Pleural Fluid to Serum Glucose Ratio in Establishing the Diagnosis of a Not So Sweet PD-Related Hydrothorax: Case Report and Literature Review ↩︎
21
PubMed Central. Pleural effusion in a peritoneal dialysis patient ↩︎
22
PubMed Central. Bilateral Pleural Effusion in Continuous Ambulatory Peritoneal Dialysis Managed by Vats Pleurodesis ↩︎
23
PubMed Central. Effectiveness and Safety of Real-Time Transthoracic Ultrasound-Guided Thoracentesis ↩︎
24
PubMed. Ultrasound guidance compared to anatomic landmark approach for thoracentesis: A systematic review and meta-analysis ↩︎
25
PubMed Central. Re-expansion Pulmonary Edema-A Rare Entity: A Thin Line between Pulmonary and Cardiac Decompensation ↩︎
26
PubMed. Reexpansion pulmonary edema ↩︎
27
European Respiratory Journal. Randomised trial of indwelling pleural catheters for refractory transudative pleural effusions ↩︎
28
Thorax. Indwelling pleural catheters in refractory transudative pleural effusions: a randomised controlled trial ↩︎
29
PubMed Central. Phantom tumor of the lung: localized interlobar effusion in congestive heart failure ↩︎
30
PubMed Central. Phantom tumor of the lung: localized interlobar effusion in congestive heart failure ↩︎
31
PubMed Central. Phantom tumor of the lung in heart failure patient ↩︎